Autobio Diagnostics Co., Ltd. (SHA:603658)
42.80
+1.12 (2.69%)
Apr 1, 2025, 2:45 PM CST
Autobio Diagnostics Revenue
Autobio Diagnostics had revenue of 1.17B CNY in the quarter ending September 30, 2024, with 3.38% growth. This brings the company's revenue in the last twelve months to 4.58B, up 4.06% year-over-year. In the year 2023, Autobio Diagnostics had annual revenue of 4.44B with 0.05% growth.
Revenue (ttm)
4.58B
Revenue Growth
+4.06%
P/S Ratio
5.40
Revenue / Employee
827.08K
Employees
5,539
Market Cap
24.45B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.44B | 2.03M | 0.05% |
Dec 31, 2022 | 4.44B | 675.71M | 17.94% |
Dec 31, 2021 | 3.77B | 787.79M | 26.45% |
Dec 31, 2020 | 2.98B | 298.70M | 11.15% |
Dec 31, 2019 | 2.68B | 749.76M | 38.85% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |